Adiponectin levels, lipid profile and glucose metabolism in patients with abdomi-nal obesity
https://doi.org/10.18705/1607-419X-2009-15-3-309-313
Abstract
Adiponectin levels, lipid profile and parameters of glucose metabolism were evaluated in patients with abdominal obesity. It was found that adiponectin level negatively correlated with body mass index (BMI). The significant correlations were found between levels of adiponectin, triglycerides, and high-density lipoprotein (HDL) cholesterol in patients with abdominal obesity. Patients with abdominal obesity and arterial hypertension had higher levels of total cholesterol, low-density lipoprotein (LDL) cholesterol, and triglycerides comparing to non-hypertensive patients with abdominal obesity. BMI increase positively correlated with insulin level and insulin resistance index estimated by homeostasis model assessment (HOMA-IR). Positive correlations were also determined between HOMA-IR and waist circumference, BMI, and adiponectin level.
About the Authors
O. Belyaeva
St Petersburg Pavlov State Medical University
Russian Federation
Russian Federation
E. A. Bazhenova
St Petersburg Pavlov State Medical University
Russian Federation
Russian Federation
A. V. Berezina
St Petersburg Pavlov State Medical University
Russian Federation
Russian Federation
O. O. Bolsha-Kova
St Petersburg Pavlov State Medical University
Russian Federation
Russian Federation
E. A. Chubenko
St Petersburg Pavlov State Medical University
Russian Federation
Russian Federation
A. E. Garanina
St Petersburg Pavlov State Medical University
Russian Federation
Russian Federation
E. I. Baranova
St Petersburg Pavlov State Medical University
Russian Federation
Russian Federation
O. A. Berkovich
St Petersburg Pavlov State Medical University
Russian Federation
Russian Federation
E. V. Shlyakhto
St Petersburg Pavlov State Medical University
Russian Federation
Russian Federation
References
1. Katzmarzyk P., Mason C. Prevalence of class I, II and III obesity in Canada // CMAJ. - 2006. - Vol. 174. - P. 156-157.
2.
3. Yusuf S., Hawken S., Ounpuu S. et al. INTERHEART Study Investigators: Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study // Lancet. - 2005. - Vol. 366. - P. 1640-1649.
4.
5. Nakano Y., Tobe T., Choi-Miura N. et al. Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma // J. Biochem. - 1996. - Vol. 120. - P. 803-812.
6.
7. Han S., Quon M., Kim J. et al. Adiponectin and cardiovascular disease // J. Am. Coll. Card. - 2007. - Vol. 49, №5. - P. 531-538.
8.
9. Guerre-Millo M. Adiponectin: An update // Diabetes Metab. - 2008. - Vol. 34. - P. 12-18.
10.
11. Yang W., Jeng C., Wu T. et al. Synthetic peroxisome proliferator-activated receptor-agonist, rosiglitazone, increases plasma levels of adiponectin in type 2 diabetic patients // Diabetes Care. - 2002. - Vol. 25. - P. 376-380.
12.
13. Weyer C, Funahashi T, Tanaka S. et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia // J. Clin. Endocrinol. Metab. - 2001. - Vol. 86, №5. - P. 1930-1935.
14.
15. Matsubara M., Maruoka S., Katayose S. Decreased plasma adiponectin concentrations in women with dyslipidemia // J. Clin. Endocrinol. Metab. - 2002. - Vol. 87. - P. 2764-2769.
16.
17. Huang K., Chen C., Chuang L. et al. Plasma adiponectin levels and blood pressures in nondiabetic adolescent females // J. Clin. Endocrinol. Metab. - 2003. - Vol. 88, №9. - P. 4130-4134.
18.
19. Вирсаладзе Д.К., Чарквиани Н.А., Адвмия Н. и соавт. Уровни адипонектина и лептина в крови при менопаузальном метаболическом синдроме // Мед. новости Грузии. - 2006. - T. 134, №5. - С. 64-67.
20.
21. Alberti G. Introduction to the metabolic syndrome // Eur. Heart J. - 2005. - Vol. 7 (Suppl. D). - P. D3-D5.
22.
23. Благосклонная Я.В., Шляхто Е.В., Бабенко А.Ю. Эндокринология: Уч. для мед. вузов. Спб.: СпецЛит, 2004. 398 с.
24.
25. Matthews D., Hosker J., Rudenski A. et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man // Diabetologia. - 1985. - Vol. 28, №7. - P. 412-419.
26.
27. Yusuf S., Hawken S., Ounpuu F. et al. INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study // Lancet. - 2004. - Vol. 364. - P. 937-952.
28.
29. MacMahon S., Cutler J ., Brittain E. et al. Obesity and hypertension: epidemiological and clinical issues// Eur. Heart. J . - 1987. - Vol. 8 (Suppl B). - P. 57-70.
30.
31. Solomon C., Manson J. Obesity and mortality: a review of the epidemiological data // Am. J. Clin. Nutr. - 1997. - Vol. 66 (suppl B). - P. 1044S-1050S.
32.
33. Obesity - prevention and managing the global epidemic. WHO Report 1998.
34.
35. Ahima R., Flier J. Adipose tissue as an endocrine organ // Trends Endocrinol. Metab. - 2000. - Vol. 11, №8. - P. 327-332.
36.
37. Higashiura K., Ura N ., Ohata J. et al. Correlations of adiponectin level with insulin resistance and atherosclerosis in Japanese male populations // Clin. Endocrinol. - 2004. - Vol. 61. - P. 753-759.
38.
39. Salmenniemi U., Zacharova J., Ruotsalainen E. et al. Association of adiponectin level and variants in the adiponectin gene with glucose metabolism, energy expenditure and cytokines in offspring of type 2 diabetic patients // J. Clin. Endocrinol. Metab. - 2005. - Vol. 90, №7. - P. 4216-4223.
40.
41. Yamauchi T., Kamon J., Ito Y. et al. Cloning of adiponectin receptors that mediate antidiabetic metabolic effects // Nature. - 2003. - Vol. 423. - P. 762-769.
42.
43. Laughlin G., Barrett-Connor E., May S. Sex-specific determinants of serum adiponectin in older adults: the role of endogenous sex hormones // Int. J. Obes. - 2007. - Vol. 31, №3. - P. 457-465.
44.
45. Lanfranco F., Zitzmann M., Simoni M. et al. Serum adiponectin level in hypogonadal men: influence of testosterone replacement therapy // Clin. Endocrinol. - 2004. - Vol. 60, №4. - P. 500-507.
46.
47. Combs T., Berg A., Rajala M. et al. Sexual differentiation, pregnancy, calorie restriction, and aging affect the adipocyte-specific secretory protein adiponectin // Diabetes. - 2003. - Vol. 52. - P. 268-276.
48.
49. Atzmon G., Pollin T., Crandall J. et al. Adiponectin level and genotype: a potential regulator of life span in humans // J. Gerontology. - 2008. - Vol. 63A, №5. - P. 447-453.
50.
51. Yamamoto Y., Hirose H., Saito I. et al. Correlation of the adipocyte-derived protein adiponectin with insulin resistance index and serum hihg-density lipoprotein-cholesterol, independent of body mass index, in the Japanese population // Clin. Science. - 2002. - Vol. 103. - P. 137-142.
52.
53. Ouchi N., Kihara S., Arita Y. et al. Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages // Circulation. - 2001. - Vol. 103. - P. 1057-1063.
54.
55. Chandran M., Phillips S., Ciaraldi T. et al. Adiponectin: more than just another fat cell hormone? // Diabetes Care. - 2003. - Vol. 26. - P. 2442-2450.
56.
57. Arita Y., Kihara S., Ouchi N. et al. Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell // Circulation. - 2002. - Vol. 105. - P. 2893-2898.
58.
59. Kubota N., Terauchi Y., Yamauchi T. et al. Disruption of adiponectin causes insulin resistance and neointimal formation // J. Biol. Chem. - 2002. - Vol. 277. - P. 25863-25866.
60.
61. Bonadonna R., Groop L., Kraemer N. et al. Obesity and insulin resistance in humans: a dose-response study// Metabolism. - 1990. - Vol. 39, №5. - P. 452-459.
62.
63. Гинзбург М.М., Козупица Г.С. Значение распределения жира при ожирении // Consilium Medicum. - 1996. - C. 30-33.
64.
65. DeFronzo R., Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease// Diabetes Care. - 1991. - Vol. 14, №3. - P. 173-194.
66.
67. Дворяшина И.В. Состояние липид-транспортной системы и ее гормональных регуляторов как факторов риска атеросклероза у юношей при ожирении. Дисс… канд. мед. наук. 1994. 156 с.
68.
69. Fruhbeck G., Gomez-Ambrosi J., Muruzabal F. et al. The adipocyte:a model for integration of endocrine and metabolic signaling in energy metabolism regulation // Am. J. Physiol. Endocrinol. Metab. - 2001. - Vol. 280. - P. E827-E847.
70.
Review
For citations:
Belyaeva O., Bazhenova E.A., Berezina A.V., Bolsha-Kova O.O., Chubenko E.A., Garanina A.E., Baranova E.I., Berkovich O.A., Shlyakhto E.V. Adiponectin levels, lipid profile and glucose metabolism in patients with abdomi-nal obesity. "Arterial’naya Gipertenziya" ("Arterial Hypertension"). 2009;15(3):309-313. (In Russ.) https://doi.org/10.18705/1607-419X-2009-15-3-309-313
Views:
961
Email this article 